NCT01547637

Brief Summary

The key objective of this study is to compare success rates of ultrasound guided obturator nerve block and anatomic landmark guided obturator nerve block as determined by neuromonitoring endpoints and surgeon observations.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 29, 2012

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 8, 2012

Completed
2 months until next milestone

Study Start

First participant enrolled

May 1, 2012

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2017

Completed
Last Updated

May 31, 2018

Status Verified

May 1, 2018

Enrollment Period

5.3 years

First QC Date

February 29, 2012

Last Update Submit

May 30, 2018

Conditions

Keywords

Obturator nerve blockRegional anesthesiaTURBT

Outcome Measures

Primary Outcomes (1)

  • Nerve conduction velocity

    Neuromonitoring technician will measure and record obturator nerve conduction velocity in pre-defined time intervals after performance of obturator nerve block.

    1 day

Study Arms (2)

Ultrasound Guided

EXPERIMENTAL

Ultrasound guided obturator nerve block will be performed after induction of general anesthesia. The anterior and posterior divisions of the obturator nerve will be identified with ultrasound. A stimulating needle will be inserted under direct ultrasound visualization. The anterior division will be blocked first. When adductor twitches are present at less than or equal to 0.5 mA, 10 ml of 2% lidocaine will be injected. Next, the needle will be re-directed under direct ultrasound visualization towards the posterior branch of the obturator nerve. After twitches \< 0.5 mA are achieved then 10 mL of 2% lidocaine will be injected when the needle tip is visualized in proximity of the posterior branch.

Procedure: Obturator nerve block

Anatomic landmark

EXPERIMENTAL

Obturator nerve block will be performed after induction of general anesthesia. The adductor magnus tendon approach will be used. A 4 cm insulated stimulating needle will be used to verify location of the obturator nerve by contraction of the thigh adductor group. The needle will be advanced until nerve stimulation is still present at less than or equal to 0.5 mA. When the appropriate nerve stimulation is achieved 10 ml of 2% lidocaine will be injected in divided doses with frequent aspiration. Nerve conduction studies will be repeated once a minute for the first 10 minutes after block completion.

Procedure: Obturator nerve block

Interventions

Peripheral obturator nerve block using 10 ml of 2% lidocaine

Also known as: anatomic obturator block
Anatomic landmark

Eligibility Criteria

Age35 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing TURBT for lateral wall bladder tumors at risk for electrical stimulation as determined by the attending surgeon.

You may not qualify if:

  • Pre-existing obturator nerve injury
  • Thigh adductor muscle weakness
  • Neuropathy
  • Local anesthetic allergy
  • Infection at the site of injection
  • Abnormal coagulation studies
  • use of neuromuscular blocking medications (if deemed necessary by attending anesthesiologist caring for the patient).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Penn State Milton S. Hershey Medical Center

Hershey, Pennsylvania, 17033, United States

Location

Study Officials

  • Jonathan A Anson, MD

    Milton S. Hershey Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assitant professor of Anesthesiology

Study Record Dates

First Submitted

February 29, 2012

First Posted

March 8, 2012

Study Start

May 1, 2012

Primary Completion

August 1, 2017

Study Completion

August 1, 2017

Last Updated

May 31, 2018

Record last verified: 2018-05

Locations